Outlook Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q3 2015 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Outlook Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q3 2015 to Q2 2024.
  • Outlook Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 60M shares, a 85.9% decline year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 60M -365M -85.9% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 60M -365M -85.9% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 425M +100M +30.8% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 60M -365M -85.9% Sep 30, 2023 10-Q 2024-08-14
Q2 2023 425M +100M +30.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 425M +100M +30.8% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 325M 0 0% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 425M +100M +30.8% Sep 30, 2022 10-K 2023-12-22
Q2 2022 325M 0 0% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 325M 0 0% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 325M +125M +62.5% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 325M 0 0% Sep 30, 2021 10-K 2022-12-29
Q2 2021 325M +125M +62.5% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 325M +125M +62.5% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 200M 0 0% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 325M +125M +62.5% Sep 30, 2020 10-K 2021-12-23
Q2 2020 200M 0 0% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 200M 0 0% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 200M 0 0% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 200M 0 0% Sep 30, 2019 10-K 2020-12-23
Q2 2019 200M 0 0% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 200M 0 0% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 200M 0 0% Dec 31, 2018 10-Q 2019-02-14
Q3 2018 200M 0 0% Sep 30, 2018 10-K 2019-12-19
Q2 2018 200M 0 0% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 200M 0 0% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 200M 0 0% Dec 31, 2017 10-Q 2018-02-14
Q3 2017 200M 0 0% Sep 30, 2017 10-K 2018-12-18
Q2 2017 200M +200M Jun 30, 2017 10-Q 2017-08-14
Q1 2017 200M +200M Mar 31, 2017 10-Q 2017-05-15
Q4 2016 200M Dec 31, 2016 10-Q 2017-02-14
Q3 2016 200M +100M +100% Sep 30, 2016 10-K 2017-12-29
Q2 2016 0 Jun 30, 2016 10-Q 2016-08-15
Q1 2016 0 Mar 31, 2016 10-Q 2016-06-27
Q3 2015 100M Sep 30, 2015 10-K 2016-12-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.